chrisvoncsefalvay/vaers-outcomes huggingface dataset:
neurological symptoms with the Pfizer COVID vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Lot number: GL0087) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Flu shot (I've never experienced these symptoms with the flu shot), for Immunization. The following information was reported: NEUROLOGICAL SYMPTOM (non-serious), outcome "unknown", described as "neurological symptoms with the Pfizer COVID vaccine".  Additional information: Caller asking how long does the Pfizer COVID booster 12 years of age and older vaccine stay in the body. The patient did not asked for this shot but wanted the flu shot. Patient had neurological symptoms with the Pfizer COVID vaccine. It started a month after the vaccine and got worse after 6 months. Patient never experienced these symptoms with the flu shot. The doctor's did not had a test to find out if it's still in the blood. There's no way to prove that it's from the vaccine.   No follow-up attempts are possible. No further information is expected.
Extreme fatigue starting at 12pm. Elevated fever reaching 103.2 by 2am, down to 101.4 by 6am, not breaking until 11am on 4-15-21. Bad headache/migraine. Nausea. Right eye became bloodshot. Hallucinations between 5-6am on 4-15-21. Injection site painful with burning sensation when pressure was applied.
This patient was given Pneumococcal vaccine on 03/12/01, later that evening he complained of pain, and redness at the site of injection. The pain was severe. Missing vaccine information not available.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 33-year-old male. Neither medical history nor concomitant medications were reported. On 12-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause of the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 18-Mar-2009 that indicated no adverse events were reported through the medical clinic. Additional information was received on 12-May-2009: product complaint investigation results.
Patient states that sore arm from vaccination never felt better and after 2 weeks has progressively gotten worse since vaccination.
This spontaneous report was received from other health professional refers to an unspecified patients of unknown age and gender. On an unknown date, an unspecified number of unspecified patients received improperly stored PEDVAXHIB (lot # K011078 and expiration date 31-MAR-2017 and lot# K025005 and expiration date 21-JUL-2017 and lot # K026533 and expiration date 07-AUG-2017) (dose and route were not reported). No adverse effect reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports received from the same source. Additional information has been requested.
"pt recv vax 4JUN96 & 19JUN96 pt devel a rash;23JUN96 pt exp fever & was not eating well;24JUN96 pt exp sz, glassy eyes & vomiting;taken to see MD & exp two more sz in car;pt was noted to be absent;"
Patient stated her arm was very hard at the injection site starting 2 days after receiving it, also had chills on and off, as well as a headache. Patient went to urgent care and was diagnosed with cellulitis. Patient started antibiotic treatment and has since felt much better.
Fatigue and headache; Fatigue and headache; This is a spontaneous report received from a contactable consumer (patient).  A 51-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 16Mar2021 14:30 (Batch/Lot Number: EN6203) age at vaccination of 51-years-old, as single dose, for covid-19 immunisation.  The patient medical history was not reported. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, administered in Arm Left on 16Feb2021 14:30 (Batch/Lot Number: EL3247), for covid-19 immunisation. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fatigue and headache on 17Mar2021 14:30. No treatment was given for the events. The patient recovered from the events on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
Narrative:  Patient received her Moderna COVID booster on 11/3/21 and on 11/4/21 had a temperature of 102.3 that was treated with acetaminophen. She continued to decline and on 11/5/21 became unresponsive and ultimately passed away at 2130 that evening. Noted she was on hospice care and had been under hospice care since 10/26/21. Two days elapsed from time of booster to time of death. No adverse reactions noted to first and second vaccine.
Passed out approximately 15 minutes after infection.  Was unconscious for approximately 30 seconds.  BP 110/30, P 90.  Would become dizzy when standing for approximately 45 minutes.  No further symptoms after the first hours of receiving the injection.  Gave history of having not eating for 15 hours before the infection was given.
Given H1N1 flu mist after had already had injectable H1N1 vaccine on 11/02/2009, no adverse reactions noted since time of 2nd vaccination.  Notified mother, mother called family doctor, who, in turn, notified the State Health Department. Nurse also gathered information from CDC help line.
pt recvd vax & had sz generalized tonic clonic w/ fever 103.2; occured w/in few hrs;
This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Mar2021 at 08:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to tree nut fruit (apples). The patient previously took codeine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication  and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021, the patient began bleeding through a pad and a pair of period panties every two hours the first two days and every four hours the last day. The blood was thin, bright red and had many chunks, which is not usual to the browner thicker and chunk less period she had. She normally had a very light three day period. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event began bleeding through a pad and a pair of period panties every two hours the first two days and every four hours the last day, the blood was thin, bright red and had many chunks was resolved on an unknown date in Jun2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 5 minutes after vaccination, pt  reported feeling chest pressure and experienced jerking movements of upper body. Pt remained alert and oriented.  Vital signs obtained as noted below. Assisted Living Facility staff administered pt's ordered nitroglycerin x 2.  Pt continued to report chest pressure and displayed jerking movements. EMS called, report given to medics, and pt transfered to hospital.
Injection Site Pain; This is a spontaneous report received from a contactable reporter(s), Program ID. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (primary immunization series completed, unknown manufacturer), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Injection Site Pain".  Additional information: Reporter calling on behalf of herself that said she received the Pfizer Covid Bivalent Vaccine, and she was asking how long the injection site pain was supposed to last. Caller stated it was day 3 of the injection site pain and declined to complete a report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
swollen lymph node in the bottom of left arm, which was the same arm which the patient had the vaccination; This is a spontaneous report from a contactable consumer, the patient.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:  EV9231), via an unspecified route of administration in the left arm on 04Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  On 05Jan2021, the patient experienced a swollen lymph node in the bottom of left arm, which was the same arm which the patient had the vaccination.  The clinical outcome of the swollen lymph node was unknown.
4 days after vaccination pt experienced severe abdominal pain the RLQ and diarrhea.  Pt was sent from village to emergency room where i evaluated, exam with significant RLQ tenderness but no rebound or guarding, some LLQ tenderness as well.   With exception of mild tachycardia and slight hypertension associated with pain, vitals were normal.
103 fever and jerking 7/19 again fever and jerking with rash on neck Pt has low appetite as well as soreness in at injection site
Patient reported to pharmacy on 11/16/15 extreme arm pain and arm movement limitation one hour after vaccine administration on 10/30/15. Patient contacted pharmacy where vaccine was administered 16 days after injection. Patient reported seeing Primary Care physician on 11/2/15 complaining of right shoulder pain. Xrays didn't show anything so patient was given steroid injection. On 11/9/15 patient again contacted PCP complaining of arm soreness and pain and then mentioned they had Flu and Pneumonia vaccine. Reported arm soreness to pharmacy on 11/16/15.
Dense rash along neck and chest and on right rib cage. It was warm to the touch. Was first noticed about 48 hrs post vaccination and lasted until 6 days post vaccination. No treatments performed.
Intense leg cramping in both legs, couldn?t sit still or lay down until my Aleve kicked in. Prickly feeling in arms when I tried to lay down. Vomiting Dizzy, nauseous, warm temperature  Migraine
This spontaneous report was received from a registered pharmacist via a company representative concerning a female patient of unknown age with heart problems (unspecified). Around 08-AUG-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. Since an unknown date, the patient was experiencing heart problems (unspecified) prior to receiving ZOSTAVAX. Approximately on 08-SEP-2012 (about a month after ZOSTAVAX was administered), the patient was admitted into an unspecified hospital for an unspecified amount of time and needed to have a pace maker implanted. It was unspecified if any lab tests were performed. On an unknown date, the patient recovered and the patient was doing well at the time of report. The causality was unknown. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA  Currently having fever up to 101.8°F, malaise, headache, and fatigue.
Vomit, cough, tired, diarrhea for 3 days. Edema, hospital ization
pt had shaking & the tips of fingers were blue & felt very hot; taken to Er where temp was 40.4C; MD followed pt & worked up w/various tests (CT of head, LP, blood work, etc); nothing was found & MD thought that it was DTP encephalopathy;
11/15/21 presents to local ED for " shortness of breath, lightheadedness over last 2-3 days". PMHx of " anemia 2/2 myelodysplasia, ESRD on HD".
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to a patient of unknown age and gender. On 05-NOV-2014 the patient was vaccinated with VARIVAX (Merck) (0.5 ml, subcutaneous, lot number and expiration date were not reported) which was improperly stored. No adverse effects reported. Additional information has been requested.
SOB and chest pain 36hr after vaccination EKG with right axis deviation and need to rule out myocarditis
TC from MD 25APR95 saw pt 22-23APR reportedly having 5-6 sz a day; MD thought it was a probable immunization rxn-referred to pediatrician; pt hospitalized; staring, rigidity w/convuls of whole body, Tx with Phenobarb dec to 3x day;
runny nose; coughing; My sinuses are blocked and I blow my nose a lot; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), COUGH (coughing), SINUS CONGESTION (My sinuses are blocked and I blow my nose a lot), HEADACHE (headache) and FATIGUE (fatigue) in a 35-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced RHINORRHOEA (runny nose), COUGH (coughing), SINUS CONGESTION (My sinuses are blocked and I blow my nose a lot), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, RHINORRHOEA (runny nose), COUGH (coughing), SINUS CONGESTION (My sinuses are blocked and I blow my nose a lot), HEADACHE (headache) and FATIGUE (fatigue) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication and treatment were not provided.
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot # L030872, expiration date 11-JUN-2018; lot # L033690, expiration date 14-JUN-2018 (exact dose and route of administration were not reported). Administered doses of the vaccine experienced the temperature excursion of 0 degrees Celsius for 8 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I started to feel my knees and feet ache, and really couldn't figure out why, and within a week I was unable to walk due to pain. I made a appointment with the Physician they took blood to test for Rheumatoid Arthritis, it came back positive with extreme high numbers. I had been tested back in 2019 and showed negative for RA.
This spontaneous report as received from a registered nurse refers to a 12 months old female patient. On 21-JAN-2013, the patient was vaccinated with a dose of VARIVAX (Merck) (lot # reported as H06327, Exp. Date: 30-AUG-2014) into right thigh, and a dose of PROQUAD (lot # reported as H015644, Exp, Date: 23-FEB-2014) into left thigh (reported as "MMRV", verbally described as MMR plus varicella). Concomitant medications included vitamins (unspecified), HIBV (unspecified carrier),Hep A (unspecified) , PNEUMOVAX 23 (Pediatric PNEUMOVAX) and influenza virus vaccine (unspecified). On 21-JAN-2013, the 12 month old patient received 6 total vaccines. Two of the vaccines, VARIVAX (Merck) and "MMRV" contained the varicella component. The patient's medical history included a "well baby visit" on 21-JAN-2013. There is no relevant laboratory data. As of 21-JAN-2013, it was unknown if the patient continued to take VARIVAX or "MMRV" and the outcome of the two doses of varicella was unknown. Additional information has been requested.
pt sent to ER 21MAY95 for fever 104, h/a, baby/joint pain;
She had lymph at her underarm; a little bit of swelling under my arm; I have a little bit of swelling under my arm where my vaccine shot was given; This is a spontaneous report from a contactable consumer or other non-health care professional (patient) from a Pfizer Sponsored Program COVAX US Support. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6207), via an unspecified route of administration, administered in arm on 20Mar2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration on 27Feb2021 as dose 1, single for COVID-19 immunization. On an unspecified date in Mar2021, the patient experienced she had lymph at her underarm; a little bit of swelling under my arm , i have a little bit of swelling under my arm where my vaccine shot was given. It was further reported that patient has an appointment for Mammography on 27Apr2021. She was asking if she can undergo Mammography after completing the 1st and 2nd dose of Covid-19 vaccine. She added that she had lymph at her underarm after taking the 2nd dose of Covid-19 vaccine last 20Mar2021. Moreover, her 1st dose was completed 1st dose last 27Feb021. Patient stated, I have a question, I took my second dose on 20Mar (not clarified) and I have a little bit of swelling under my arm where my vaccine shot was given. Also, I will be having on 27Apr, a mammogram, so my question is, is it safe for me to do the mammogram or do I need to reschedule or wait because I was thinking about it. She further stated, I just want answer to my question because I was waiting for five hours and I just want to know, is it is safe or not. In response to further probing, patient stated, I have given already all my information to the first person that I spoke to first, I gave her all my information, to that first lady. So, I will just call the other department to make sure. (further clarification unknown if consumer called in Pfizer Drug Safety earlier, hence report type captured as initial report). She stated, I do not know about the expiration date, I took the first dose on 27Feb (not clarified). Reason of delay: Daily spike of incoming calls due to COVID19 vaccine. The clinical outcome of all the events was reported as unknown.  No follow-up attempts are needed. No further information is expected.
Partial hearing loss, tinnitus. Both ears feel "muffled" and "stuffy" and are ringing loudly. First, the left ear started feeling that way, and then the next day, the right ear started feeling it and the left ear got worse.
Joint and bone pain in legs, right shoulder 12 hours after vaccine. Decreased pain, increased fatigue 24 hours after vaccine. Mild pain at site of injection.
Intense arm pain, couldn?t lift arm for over a week. Still have arm pain and it is December.  Just received flu vaccine and had a fever and body aches and my inject site from Covid vaccine was in pain.
Acute biliary pancreatitis. She was seen urgently by bariatric surgery and gastroenterology and underwent an emergent ERCP.  Patient did incidentally did test positive for SARS coronavirus 2 without any evidence for any active Covid infection. Patient ERCP through gastrostomy tube performed by bariatric surgery.  She had a biliary sphincterotomy and balloon sweep with resulting pus, sludge, and stone debris.  She had a stent placed in the pancreatic duct.  Patient initially transferred back to the medical floor but had worsening hypotension and respiratory status.  She had worsening hypercapnia requiring intubation.  Patient was treated with ventilatory support, pressors, and broad-spectrum antibiotics.  Her blood cultures returned positive for E. coli, and her antibiotics were narrowed to ceftriaxone.  She was able to wean off of pressors and the ventilator over several hospital days and was extubated on hospital day #6. Continued hospital management for all problems and discharge after 7 days. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
blurr vision ,dizziness ,sweating and BP 94/74 . COLD COMPRESS APPLIED AND EMS WAS CALLED
Hasn't been well since the second dose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Hasn't been well since the second dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2022, the patient experienced MALAISE (Hasn't been well since the second dose). At the time of the report, MALAISE (Hasn't been well since the second dose) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter.   This case was linked to MOD-2023-707334 (Patient Link).
Approximately 1 month after receiving the second dose of the Gardasil vaccine (manufactured by Merck - I am unable to load that in the information section below), I began experiencing numbness in my right leg. The numbness was persistent and progressive - it began in the right leg, but soon spread to the left leg, as well as my face and tongue. I also experienced poor balance, poor vision, confusion, and overall weakness. I was admitted to the hospital 3 weeks later, and kept for one week while receiving intravenous corticosteroids as treatment. 8/24/09 consultant records 1/09-received for numbness of right leg below knee right face and tongue numbness between Oct 07 and Feb 08 when symptoms improved and then in March 08 recurrent symptoms. Developed diplopia, dizziness, cognitive impairment, abdominal problems and fatigue. Impression: MS.